Study Stopped
Due to lack of funding
Safety and Efficacy of Plant-based Diets in Hemodialysis Patients
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The purpose of this proof-of-concept controlled-feeding study is to evaluate the impact of plant-rich diets, with and without high-potassium fruits and vegetables, on phosphorus and potassium homeostasis in hemodialysis (HD) patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2019
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2017
CompletedFirst Posted
Study publicly available on registry
May 30, 2017
CompletedStudy Start
First participant enrolled
January 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedFebruary 1, 2019
January 1, 2019
3.6 years
May 25, 2017
January 30, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pre-dialysis serum potassium concentrations.
Pre-dialysis blood samples will be collected by dialysis center staff, and delivered to the Tisch Laboratory by study staff on each dialysis day.
Day 1
Pre-dialysis serum phosphorus concentrations.
Post-prandial blood tests will be obtained after the participant consumed the standard meal providing 20% of estimated energy requirements corresponding to the research diet
Day 7
Study Arms (1)
Hemodialysis Patients
EXPERIMENTALPhosphorus and potassium homeostasis will be assessed based on the concentrations of phosphorus and potassium in blood samples collected in fasting, post-prandial, mid-afternoon, pre-dialysis states, as well as the concentrations of phosphorus-regulatory factors, calcitriol, parathyroid hormone and fibroblast growth factor-23. The participants will be transitioned gradually to a plant-rich diet
Interventions
Adapted from National Kidney Foundation guidelines for HD1 * Animal only Protein * Refined only Grains * Limit Dairy * Low-k only
•¼ Animal, ¾ Plant Proteins •½ Refined, ½ Whole Grain * Limit Dairy, provide Soymilk Dairy * Low-k only Fruit and Vegetables
•¼ Animal, ¾ Plant Proteins * Refined, ½ Whole Grain •Limit Dairy, provide Soymilk Dairy * Low-k, Fruit and Vegetables * High-k Fruit and Vegetables
Eligibility Criteria
You may qualify if:
- Receiving thrice-weekly outpatient HD treatments for end-stage renal disease
- month mean serum potassium and phosphorus concentrations of \>4.5 mEq/L and \>4.0 mg/dL, respectively
- No prior episodes of moderate-severe hyperkalemia (potassium ≥6.5 mEq/L) in the past 6 months
- Deemed appropriate for the intervention by the patient's nephrologist, considering the patient's prognosis, cognition and pending treatments (e.g., kidney transplant)
You may not qualify if:
- Change in medications that alter potassium homeostasis (e.g., RAAS inhibitors, diuretics, beta-blockers) in the last month
- Diagnosed with bowel diseases or syndromes (e.g., bowel obstruction, major GI surgery, short-bowel syndrome, irritable bowel syndrome, inflammatory bowel disease, chronic diarrhea)
- Anemic, defined as a serum hemoglobin concentration \<9.0 g/dL
- Inadequate dialysis efficacy, defined as a Kt/V of \<1.2
- Dietary restrictions (e.g., allergies) or otherwise unable/unwilling to adhere to study diets (excludes dietary restrictions on high-potassium foods)
- Pregnant or planning to become pregnant during the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David St Jules, MD
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2017
First Posted
May 30, 2017
Study Start
January 30, 2019
Primary Completion
September 1, 2022
Study Completion
September 1, 2023
Last Updated
February 1, 2019
Record last verified: 2019-01